Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis

BACKGROUND: Humoral response against sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after two doses of BNT162b2 (Pfizer-BioNTech) has been proven to be less intense in maintenance dialysis patients as compared with healthy subjects, leading the French authorities to recommend a third i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekervel, Marine, Henry, Nicolas, Torreggiani, Massimo, Pouteau, Lise-Marie, Imiela, Jean-Paul, Mellaza, Chloé, Garnier, Anne-Sophie, Dujardin, Amaury, Asfar, Marine, Ducancelle, Alexandra, Paquin, Axelle, Blanchi, Sophie, Besson, Virginie, Piccoli, Giorgina Barbara, Augusto, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573007/
https://www.ncbi.nlm.nih.gov/pubmed/34754430
http://dx.doi.org/10.1093/ckj/sfab152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573007/
https://www.ncbi.nlm.nih.gov/pubmed/34754430
http://dx.doi.org/10.1093/ckj/sfab152

Ejemplares similares